Dianthus Therapeutics, Inc. · 5 hours ago
Senior Clinical Data Manager
Dianthus Therapeutics is developing innovative therapies for patients with severe autoimmune diseases. The Senior Clinical Data Manager will oversee clinical data management processes for ongoing studies, ensuring high-quality and regulatory-compliant data throughout the clinical trial lifecycle.
BiopharmaBiotechnologyHealth Care
Responsibilities
Responsible for relationships with Data Management partners (eg, CROs and vendors)
Oversight of outsourced study-related DM activities including CRF design, data collection, edit checks and listings reviews, data reconciliation (SAEs, labs, other external data), medical coding, UAT testing, database lock and archival of DM documents
Accountable for ensuring data quality and timeliness of DM deliverables are met and align with company goals
Maintain data integrity in compliance with GCP, relevant SOPs and regulatory requirements by reviewing data processes and filing documentation in the Trial Master File
Represent DM during Investigator Meetings, CRA training, on-site visits, company or department meetings
Other related duties as may be determined or assigned
Qualification
Required
BS in relevant discipline. Life Sciences experience is a plus
Strong understanding of DM related systems, technologies and standards including data analytics platforms
Comprehensive knowledge of drug development and clinical research processes, GCP guidelines and regulations related to clinical data management
Self-motivated and able to work autonomously as well as take direction and work within a high-functioning and collaborative team environment
Detail-oriented with strong verbal and written communication skills
Ability to build relationships internally and with external partners
Highest levels of professionalism, confidence, personal values and ethical standards
Company
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$639.5M2025-09-09Post Ipo Equity· $288M
2024-01-22Post Ipo Equity· $230M
2023-09-12IPO
Leadership Team
Recent News
Clinical Trials Arena
2025-12-25
Company data provided by crunchbase